Remote Patient Monitoring and Telehealth: 5 Years of Growth Forecast for $54 Billion Market

  Before COVID-19, the telehealth industry was evolving slowly with slight gains annually.  Today, the pandemic has thrust the world into a new era of remote life, including managing, monitoring and treating patients and their health conditions at a pace never experienced before.  As a result of COVID-19, the global market for patient monitoring and […]

3 Growth Trends in $472 Billion Global Medical Device Market

  COVID-19, mergers & acquisitions, and innovation spurred notable gains in the sale of medical devices in 2020   The global market for medical devices rose to $472 billion in 2020, increasing 5.1% for the year over 2019, according to new data published in The Global Market for Medical Devices, 11th Edition, the latest report […]

At-Home Testing Expanding Reach Beyond COVID-19 Pandemic

Over the years, the increasing introduction of transportable, portable, and handheld medical instruments has resulted in the migration of point-of-care (POC) testing from the hospital environment to a range of medical and non-medical environments including the workplace, home, disaster care and most recently, convenience clinics. In the face of the ongoing global COVID-19 pandemic, the […]

Point of Care Test Market is Ravaged, and Helped By Pandemic

Kalorama Information reported a mixed result with point of care testing, defined by tests that can deliver a result meaningful during a patient visit with a provider or on their own.  In 2020, sales of POC testing reached $29,316 million, according to Kalorama Information, a sister publication to Lab Pulse.  That’s up double digits from […]

Watch the Companies That Make Cell and Gene Therapies For Pharma, Says New Report

There’s much talk about cell and gene therapy but a new report from a leading market research firm says that there’s a growing market over nearly two billion dollars for companies that make the cell and gene therapies. In 2020, the total global cell and gene therapy BCMO market reached $1,842 million. Over the following […]

Global Biomarker Test Product Sales to Reach $63 Billion in 2027

Total global sales of biomarker test products are projected to reach nearly $63 billion in 2027 with the majority of sales coming from the United States, Western Europe, and Japan, according to new data by leading medical market research publisher Kalorama Information in the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, […]

COVID-19: A Vaccine Solution?

Not since the Swine Flu epidemic of 2009 has there been this amount of emphasis on vaccines and vaccine development.  This new infectious disease threat with no anti-viral, nor vaccine is causing significant concern among healthcare providers, governments and the public.  Last-resort measures such as school closings and curfews in place in the United States […]

Top 10 Life Science and Healthcare Market Predictions for 2020

Highly effective cancer therapies. Handheld hematology analyzers. A new and untapped world market. Social media selling life science tools. Science and Medicine Group publications, including Kalorama Information, Strategic Directions International (SDi), Bioinformatics, and IMV have made various projections for the new year in imaging, diagnostics, biotechnology, and life science instrument and supplies that can help […]

New Study Predicts 1,000+ Urgent Care Centers Opening in the US Over Next Five Years

A New study from Kalorama Information said that the number of urgent care centers in the US is expected to increase from approximately 10,600 currently to more than 12,000 by 2023. The report, The Market for U.S. Urgent Care projects a growing market for the urgent care center business and a growing market for suppliers […]

What Does The “Second Wave” of 2018/19 Flu Season Mean for IVD Markets?

The CDC reports a late peak and possible second wave to what was previously thought to be a weaker flu season compared to recent years. This is important for IVD makers, as respiratory IVD markets are driven to a great extent by the severity of the flu season. While the total number of cases remains […]